GLP-1 medications significantly suppress appetite, which can lead to inadequate protein consumption during rapid weight loss
doi:10.1007/s00018-005-5163-7
Noninvasive and oral alternatives are widely regarded as representing one of the most significant near-term commercial opportunities in obesity and diabetes treatment
For best results, use in conjunction with a calorie-controlled diet and regular exercise
Tinnitus is not dangerous
[3] Other common adverse effects reported during the clinical trials include back pain, upper respiratory tract infections, melanocyte naevus, decreased appetite, migraine, dizziness, weakness, fatigue, lethargy, sleepiness, hot flashes, abdominal pain, diarrhea, vomiting, flushing, development of warts, spots, and freckles, and itchy skin (between 1% and 10% of people)